Found: 3
Select item for more details and to access through your institution.
Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double‐Blind, Active‐Controlled Proof‐of‐Concept Phase IIa Trial
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 6, p. 879, doi. 10.1002/art.42415
- By:
- Publication type:
- Article
Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 5, p. 932, doi. 10.1002/art.40054
- By:
- Publication type:
- Article
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.
- Published in:
- Rheumatology & Therapy, 2019, v. 6, n. 4, p. 503, doi. 10.1007/s40744-019-00167-6
- By:
- Publication type:
- Article